BiostatisticianParatek Pharmaceuticals, Inc.King of Prussia, PA, United States
Disclosure information not submitted.
336 - Microbiological Outcomes of Oral Omadacycline Treatment in Adults with Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Caused by Mycobacterium abscessus complex (MABc): Results from a Phase 2, Double-blind, Randomized, Placebo-controlled, Multi-center Trial
Tuesday, October 21, 202511:06 AM - 11:18 AM US ET
